European practices of genetic information and insurance: lessons for the Genetic Information Nondiscrimination Act.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2008-07-16

• Fields of study

  Law, Medicine

• Identifiers
  DOI 10.1001/jama.2008.62PMID 18632546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Congress passes bill to ban discrimination based on individuals' genetic makeup.

  2008cited by this paper
• Genetics bill cruises through Senate

  2008cited by this paper
• Genetics and Insurance: New Technologies, New Policies, New Responsibilities

  2008cited by this paper
• Prohibiting genetic discrimination.

  2007cited by this paper
• Genetics 'risk carriers' and life style 'risk-takers' : which risks deserve our legal protection in insurance?

  2007cited by this paper
• Risks in the Making: Travels in Life Insurance and Genetics

  2006cited by this paper
• Making the normal deviant: the introduction of predictive medicine in life insurance.

  2006cited by this paper
• Insurance, unfair discrimination, and genetic testing.

  2005cited by this paper
• Genetic information and testing in insurance and employment: technical, social and ethical issues

  2003cited by this paper

• Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries

  2024cites this paper
• Opportunities and Challenges for Genetic Studies of End-Stage Renal Disease in Canada

  2018cites this paper
• Genetic Bragging as a Speech Act: From Fictional to Non-fictional Discourse

  2018cites this paper
• Which attributes of whole genome sequencing tests are most important to the general population? Results from a German preference study

  2018cites this paper
• Comparative Approaches to Genetic Discrimination: Chasing Shadows?

  2017cites this paper
• Overview of Policy, Ethical, and Social Considerations in Genomic and Personalized Medicine

  2017cites this paper
• Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.

  2017cites this paper
• 11 Pharmacogenetics Role in Forensic Sciences

  2017cites this paper
• BIOLOGICAL POSITIVISM: EVOLUTION, DEVELOPMENT AND CONTEMPORARY APPLICATIONS

  2017cites this paper
• Genetic Diagnosis of Renal Diseases: Basic Concepts and Testing

  2016cites this paper
• A Symptomatic Reading of the Discourse on Genetic Discrimination IFS WORKING PAPERS

  2016cites this paper
• If you build it, they will come: unintended future uses of organised health data collections

  2016cites this paper
• From Systems Understanding to Personalized Medicine: Lessons and Recommendations Based on a Multidisciplinary and Translational Analysis of COPD.

  2016cites this paper
• Implications for Health and Life Insurances and Other Legal Aspects of Genetic Testing

  2015cites this paper
• Public Perceptions of Pharmacogenetics

  2014cites this paper
• Genomics and personalised whole-of-life healthcare.

  2014cites this paper
• Genomic testing in cancer: Patient knowledge, attitudes, and expectations

  2014cites this paper
• How Political Cultures Affect Governance Efforts To Protect “Posted Genes”: Insights From Germany

  2014cites this paper
• Predictive Medicine for Chronic Patients in an Integrated Care Scenario. Chronic Obstructive Pulmonary Disease as Use Case

  2014cites this paper
• Priority Medicines for Europe and the World "A Public Health Approach to Innovation"

  2013cites this paper
• Health Insurance, Employment, and the Human Genome: Genetic Discrimination and Biobanks in the United States

  2013cites this paper
• Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease

  2013cites this paper
• Moving beyond Public Fear of Genetic Discrimination

  2013cites this paper
• Implementation of the CDC translational informatics platform - from genetic variants to the national Swedish Rheumatology Quality Register

  2013cites this paper
• Awareness of the US Genetic Information Nondiscrimination Act of 2008: an online survey

  2013cites this paper
• Risk terminology in biobanking and genetic research: What's in a name?

  2013cites this paper
• Molecular genetic testing and the future of clinical genomics

  2013cites this paper
• Priority Medicines for Europe and the World " A Public Health Approach to Innovation " Update on 2004 Background Paper Background Paper 7 . 4 Pharmacogenetics and Stratified Medicine

  2013cites this paper
• Fear of genetic discrimination in Japan.

  2012cites this paper
• Your genes in insurance: from genetic discrimination to genomic solidarity.

  2012cites this paper
• Technical, Ethical and Social Issues in the Bioprediction of Addiction Liability and Treatment Response

  2012cites this paper
• Foreword: The Neuroethics of Drug Addiction

  2012cites this paper
• Genetic and clinical characterisation of arrhythmogenic cardiomyopathy

  2012cites this paper
• The Genetic Information Nondiscrimination Act (GINA): Public Policy and Medical Practice in the Age of Personalized Medicine

  2012cites this paper
• Utilization of conjoint analysis to elicit preferences for genetic testing for Alzheimer's disease

  2011cites this paper
• Social and ethical implications of BRCA testing.

  2011cites this paper
• Pharmacogenetics Role in Forensic Sciences

  2011cites this paper
• Ethical and social issues in pharmacogenomics testing.

  2010cites this paper
• PHENOTYPES FOR PREDICTION : GENE EXPRESSION AND GENETIC EXCEPTIONALISM

  2010influential citation
• Obtaining insurance after DNA diagnostics: a survey among hypertrophic cardiomyopathy mutation carriers

  2010cites this paper
• Community interest in predictive genetic testing for susceptibility to major depressive disorder in a large national sample

  2010cites this paper
• Gene-environment interactions in occupational asthma

  2010cites this paper
• Keeping the GINA in the bottle: assessing the current need for genetic non-discrimination legislation in Canada

  2010cites this paper
• Hypertrophic cardiomyopathy: towards an optimal strategy

  2010cites this paper
• De rol van evidence, politiek en geschiedenis bij de constructie van ‘verzekerbaarheid’

  2009cites this paper
• Evidence-based underwriting in the molecular age: the politics of reinsurance companies towards the genetics issue

  2009cites this paper
• Legislation on genetic testing and the practice of oncology.

  2009cites this paper
• Two cheers for GINA?

  2009cites this paper
• Genotype–phenotype databases: challenges and solutions for the post-genomic era

  2009cites this paper
• How Will GINA Influence Participation in Pharmacogenomics Research and Clinical Testing?

  2009cites this paper
• When to Conduct a Renal Impairment Study During Drug Development: US Food and Drug Administration Perspective

  2009cites this paper
• Statistical applications in nutrigenomics : analyzing multiple genes and proteins in relation to complex diseases in humans

  2008cites this paper
• Penn Carey Law: Legal Scholarship Repository Penn Carey Law: Legal Scholarship Repository

  year unknowncites this paper